- UNH stock jumps more than 6% on Trump presidential election win.
- Health insurers that manage Medicare Advantage programs saw their share prices rise.
- The Biden administration has been attempting to lower reimbursement rates for senior healthcare.
- Companies focused on Medicaid care swung to losses as Republicans are less favorable to the poor.
UnitedHealth Group (UNH), the single largest weighting in the Dow Jones Industrial Average (DJIA), has risen about 6% on Wednesday in light of Donald Trump’s reelection to the US presidency.
Though states are continuing to count the outstanding vote, Trump has secured enough electoral votes to ensure his rise to the 47th presidency of the United States, an office he will enter on January 20, 2025. Additionally, his Republican Party has won a majority in the Senate, the upper house of Congress. Control of the House of Representatives, the lower chamber, is still uncertain for now.
The DJIA has surged more than 3% on Wednesday, easily overpowering normally more volatile S&P 500 and NASDAQ indices, which have gained closer to 2% each.
UnitedHealth Group stock news
UnitedHealth stock shot up to just under $600 on Wednesday as a Trump presidency is expected to offer better reimbursement rates for health insurers in the United States. The Biden administration had been strict on reimbursement levels under the Medicare program that pays for healthcare among seniors. In fact, President Biden’s administration has attempted to cut reimbursement rates for Medicare.
In particular, insurers that run Medicare Advantage programs saw the most gains. These programs are private versions of the government's main government-led enrollment program.
The positivity around a Trump presidency was felt throughout the health insurance industry. CVS Health (CVS), which owns insurer Aetna, bounced 11% higher, but that was a reaction to third-quarter earnings as well. Humana (HUM) stock also advanced at a healthy clip.
Meanwhile, insurers and healthcare providers like Elevance Health (ELV) and Centene (CNC) that focus on providing care through the government’s Medicaid program that offers healthcare to the lower income segment saw their shares slide.
CVS bested its consensus revenue figure by a wide margin, but the company missed the bottom line consensus due to restructuring charges. The CVS segment that operates Aetna saw revenue of $33 billion, which rose 26% YoY. However, premium deficiency reserves topped $1 billion, which led to a profit loss in the segment.
UnitedHealth Group stock forecast
UnitedHealth stock is nearing resistance at $608. This level was difficult to maintain on September 4 and October 14. There have been other instances in the past two months where rallies dissipated once they rose above $600.
UNH stock has moved lower on Wednesday after reaching an early intraday high of $605.50. Shares sank back to the $590s by mid-session. Expect another attempt at $608 and for UNH to maintain that price level as traders grow excited about a Trump presidency that should reliably be more pro-business and less serious about regulatory matters.
UNH daily stock chart
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD challenges 1.0500 on Dollar's bounce
The US Dollar now picks up further pace and weighs on the risk-associated assets, sending EUR/USD to the boundaries of the key 1.0500 region and at shouting distance from its 2024 lows.
GBP/USD remains weak and puts 1.2600 to the test
GBP/USD remains on the back foot and now approaches the key support at 1.2600 the figure in response to the resurgence of the bid bias in the Greenback.
Gold extends gains beyond $2,660 amid rising geopolitical risks
Gold extends its bullish momentum further above $2,660 on Thursday. XAU/USD rises for the fourth straight day, sponsored by geopolitical risks stemming from the worsening Russia-Ukraine war. Markets await comments from Fed policymakers.
BTC hits an all-time high above $97,850, inches away from the $100K mark
Bitcoin hit a new all-time high of $97,852 on Thursday, and the technical outlook suggests a possible continuation of the rally to $100,000. BTC futures have surged past the $100,000 price mark on Deribit, and Lookonchain data shows whales are accumulating.
A new horizon: The economic outlook in a new leadership and policy era
The economic aftershocks of the COVID pandemic, which have dominated the economic landscape over the past few years, are steadily dissipating. These pandemic-induced economic effects are set to be largely supplanted by economic policy changes that are on the horizon in the United States.
Best Forex Brokers with Low Spreads
VERIFIED Low spreads are crucial for reducing trading costs. Explore top Forex brokers offering competitive spreads and high leverage. Compare options for EUR/USD, GBP/USD, USD/JPY, and Gold.